/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

I

Ignacio I. Wistuba

Moffitt Cancer Center(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

2.8K

Papers

104.1K

Citations

153

h-index

724

i10-index

Ignacio I. Wistuba is an academic researcher from Moffitt Cancer Center. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & RNA modifications and cancer & Cancer Genomics and Diagnostics. The author has an h-index of 153, co-authored 2404 publications.

ORCID: 0000-0003-3365-6340

Research Topics

Lung Cancer Treatments and Mutations RNA modifications and cancer Cancer Genomics and Diagnostics Cancer Immunotherapy and Biomarkers Lung Cancer Research Studies

Papers by this author

works

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

2011 · Journal of Thoracic Oncology · 4,773 citations

https://doi.org/10.1097/jto.0b013e318206a221

William D. Travis Élisabeth Brambilla Masayuki Noguchi Andrew G. Nicholson

Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation

2018 · Cell · 2,277 citations

https://doi.org/10.1016/j.cell.2018.03.034

Tathiane M. Malta Artem Sokolov Andrew J. Gentles Tomasz Burzykowski

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression

2014 · Nature Communications · 970 citations

https://doi.org/10.1038/ncomms6241

Limo Chen Don L. Gibbons Sangeeta Goswami María Angélica Cortez

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

2021 · Cancer Cell · 886 citations

https://doi.org/10.1016/j.ccell.2020.12.014

Carl M. Gay C. Allison Stewart Elizabeth M. Park Lixia Diao

Co-occurring Genomic Alterations Define Major Subsets of <i>KRAS</i> -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities

2015 · Cancer Discovery · 883 citations

https://doi.org/10.1158/2159-8290.cd-14-1236

Ferdinandos Skoulidis Lauren A. Byers Lixia Diao Vassiliki A. Papadimitrakopoulou

Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer

2019 · Cancer Discovery · 841 citations

https://doi.org/10.1158/2159-8290.cd-18-1020

Triparna Sen B. Leticia Rodriguez Limo Chen Carminia Maria Della Corte

Research topics

topics

Lung Cancer Treatments and Mutations

RNA modifications and cancer

Cancer Genomics and Diagnostics

Cancer Immunotherapy and Biomarkers

Lung Cancer Research Studies

Chat about Author

Papers

Chat

Click to start Chat